Showing results (1-10 of 50) with videos related to
Sort By:
Pageof 5
Experimental Biology and Medicine (Maywood, N.J.)|April 28, 2011
Naturally occurring, tumor-specific, therapeutic proteinsKonstantinos Argiris, Chrysoula Panethymitaki, Mahvash TavassoliCell Death Discovery|September 1, 2020
Inside the hypoxic tumour: reprogramming of the DDR and radioresistanceKatheryn Begg, Mahvash TavassoliAdvances in Experimental Medicine and Biology|July 9, 2014
Signalling of ApoptinJessica Bullenkamp, Mahvash TavassoliTranslational Oncology|January 19, 2021
Hypoxia-induced therapy resistance: Available hypoxia-targeting strategies and current advances in head and neck cancerVictoria L Codony, Mahvash TavassoliOral Oncology|October 4, 2020
Portrait of a CAF: The story of cancer-associated fibroblasts in head and neck cancerMarcos Custódio, Adrian Biddle, Mahvash TavassoliJournal of Cell Science|February 3, 2005
Functional analysis of TbARL1, an N-myristoylated Golgi protein essential for viability in bloodstream trypanosomesHelen P Price, Chrysoula Panethymitaki, David Goulding, et al.Cancers|December 11, 2019
Cancer Treatment Goes Viral: Using Viral Proteins to Induce Tumour-Specific Cell DeathJasmine Wyatt, Manuel M Müller, Mahvash TavassoliCell Death Discovery|June 26, 2024
Crosstalk between CAFs and tumour cells in head and neck cancerXinyang Li, Celia González-Maroto, Mahvash TavassoliCell Death & Disease|November 5, 2022
EGFR-induced suppression of HPV E6/E7 is mediated by microRNA-9-5p silencing of BRD4 protein in HPV-positive head and neck squamous cell carcinomaDanupon Nantajit, Luana Presta, Thomas Sauter, et al.Cancers|January 25, 2025
Targeting Fibroblast-Derived Interleukin 6: A Strategy to Overcome Epithelial-Mesenchymal Transition and Radioresistance in Head and Neck CancerXinyang Li, Hugues Escoffier, Thomas Sauter, et al.Pageof 5